PREDILIFE
Develops AI-powered solutions to assess individual risk for major diseases.
ALPRE | PA
Overview
Corporate Details
- ISIN(s):
- FR0010169920 (+5 more)
- LEI:
- 9695006IK5NBKHQU9116
- Country:
- France
- Address:
- 39 RUE CAMILLE DESMOULINS, 94800 VILLEJUIF
- Website:
- https://www.predilife.com/en/
- Industry:
- Other human health activities
Description
PREDILIFE specializes in predictive medicine, developing solutions to assess an individual's risk of developing major diseases. The company's approach integrates medical data, such as genetic testing and imaging, with artificial intelligence and mathematical models to create personalized risk profiles. Its primary offerings are predictive health check-ups, including a specialized test for assessing the 5-year risk of breast cancer (MammoRisk®) and a multi-condition check-up that evaluates the risk for several common cancers (lung, prostate, colorectal, melanoma) and cardiovascular disease. Based on these risk profiles, PREDILIFE provides personalized follow-up and preventive recommendations. The company offers its end-to-end solution, which includes remote consultations, to businesses, insurers, and healthcare professionals to facilitate wider access to preventive care.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-24 18:30 |
Predilife met à disposition son rapport financier semestriel 2025
|
French | 358.5 KB | ||
| 2025-10-09 18:30 |
PREDILIFE : Résultats semestriels 2025 - Multiplication du chiffre d'affaires p…
|
French | 731.9 KB | ||
| 2025-07-22 19:00 |
PREDILIFE ANNONCE LA RÉALISATION D'UN PLACEMENT PRIVE DE 300 K EUR PERMETTANT D…
|
French | 498.0 KB | ||
| 2025-06-11 19:00 |
Avenant au contrat de liquidité conclu avec TSAF
|
French | 164.0 KB | ||
| 2025-06-06 20:15 |
Mise à disposition du rapport financier annuel 2024
|
French | 383.3 KB | ||
| 2025-05-15 08:00 |
RÉSULTATS ANNUELS 2024 - PERSPECTIVES DE CROISSANCE ET DE PARTENARIAT 2025
|
French | 283.1 KB | ||
| 2025-04-30 18:30 |
REPORT DE LA PUBLICATION DES RESULTATS ANNUELS 2024 ET DU RAPPORT FINANCIER ANN…
|
French | 162.4 KB | ||
| 2025-01-17 18:00 |
Bilan semestriel au 31/12/2024 du contrat de liquidité PREDILIFE
|
French | 417.3 KB | ||
| 2025-01-08 18:30 |
PREDILIFE DOUBLE SON VOLUME DE VENTE EN 2024 ET ANTICIPE UNE FORTE CROISSANCE P…
|
French | 248.6 KB | ||
| 2024-12-17 20:00 |
PREDILIFE ANNONCE LA RÉALISATION D'UNE LEVÉE DE FONDS DE 779 000 EUROS DANS LE …
|
French | 396.7 KB | ||
| 2024-11-12 08:30 |
Predilife lance une émission d'obligations de 2M EUR à un taux de 8,5% par an s…
|
French | 898.9 KB | ||
| 2024-11-07 18:30 |
Réalisation de l'apport partiel d'actif de MammoRisk à une valorisation de 202 …
|
French | 225.6 KB | ||
| 2024-10-30 19:00 |
Predilife met à disposition son rapport financier semestriel 2024
|
French | 158.4 KB | ||
| 2024-10-28 08:30 |
Résultats semestriels 2024 - Perspectives de croissance 2024
|
French | 256.4 KB | ||
| 2024-10-21 18:30 |
Le Groupe Rocher prend une initiative majeure pour la santé des femmes et propo…
|
French | 236.4 KB |
Automate Your Workflow. Get a real-time feed of all PREDILIFE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PREDILIFE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PREDILIFE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-30 | N/A | Other | Buy | 200 | 960.00 EUR |
| 2024-07-04 | N/A | Other | Buy | 400 | 2,720.00 EUR |
| 2024-06-26 | N/A | Other | Buy | 2,000 | 12,000.00 EUR |
| 2024-06-18 | N/A | Other | Buy | 500 | 2,800.00 EUR |
| 2024-05-02 | N/A | Other | Sell | 8,500 | 204,000.00 EUR |
| 2024-04-26 | N/A | Other | Buy | 599 | 2,635.60 EUR |
| 2024-02-28 | N/A | Other | Buy | 1,600 | 6,720.00 EUR |
| 2024-02-26 | N/A | Other | Buy | 500 | 2,150.00 EUR |
| 2024-02-22 | N/A | Other | Buy | 500 | 2,250.00 EUR |
| 2024-02-20 | N/A | Other | Other | 1,000 | 4,800.00 EUR |
Peer Companies
